Acutus Medical, Inc. (AFIB)
OTCMKTS: AFIB · Delayed Price · USD
0.0590
+0.0140 (31.11%)
May 17, 2024, 3:49 PM EDT - Market closed
Company Description
Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally.
Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs.
Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.
Acutus Medical, Inc.
Country | Canada |
Founded | 2011 |
IPO Date | Aug 6, 2020 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 230 |
CEO | Takeo Mukai |
Contact Details
Address: 2210 Faraday Ave, Suite 100 Carlsbad, California 92008 United States | |
Phone | 442-232-6080 |
Website | acutusmedical.com |
Stock Details
Ticker Symbol | AFIB |
Exchange | OTCMKTS |
Fiscal Year | January - December |
Reporting Currency | USD |
IPO Price | $18.00 |
CIK Code | 0001522860 |
CUSIP Number | 005111109 |
ISIN Number | US0051111096 |
Employer ID | 45-1306615 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Takeo Mukai | Chief Executive Officer and Chief Financial Officer |
Gary W. Doherty | Senior Vice President of Finance |
Latest SEC Filings
Date | Type | Title |
---|---|---|
May 17, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
May 17, 2024 | 8-K | Current Report |
May 16, 2024 | 25-NSE | Filing |
May 9, 2024 | 10-Q | Quarterly Report |
May 9, 2024 | 8-K | Current Report |
May 3, 2024 | 8-K | Current Report |
Apr 25, 2024 | ARS | Filing |
Apr 25, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
Apr 25, 2024 | DEF 14A | Other definitive proxy statements |
Apr 4, 2024 | 144 | Filing |